Therefore, whether the expression of CK20 in tumor tissues and the serum level of CK20 are different between LCC and RCC and whether serum CK20 could distinguish LCC from RCC need to be further studied. The gene discussed is KRT20; the disease is leukoencephalopathy with calcifications and cysts.